arrow
T

Tiziana Perin

centro di riferimento oncologico di aviano (c
H指数:32
被引数:3,995

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nanoformulation of a Pin1 inhibitor potentiates the efficacy of liposomal doxorubicin in second-line therapy for ovarian cancer

一种Pin1抑制剂的纳米制剂能够增强脂质体多柔比星在卵巢癌二线治疗中的疗效

2025-11-130
PRE
A comprehensive luminal breast cancer patient-derived xenografts (PDX) library to capture tumor heterogeneity and explore the mechanisms of resistance to CDK4/6 inhibitors
2024-10-250
OA
Capturing tumor heterogeneity to personalize therapy in young patients with hormone receptor positive breast cancer
2024-03-220
PRE
Clinical and biological predictors of lymph node involvement in patients with early breast cancer for adjuvant treatment personalization
2023-03-010
PRE
Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples (vol 20, 231, 2022)
2023-01-262
OAAI
Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples

全hr-hpv基因分型的临床验证HPV Selfy检测根据临床医生收集和自行收集的样本进行宫颈癌筛查的HPV检测要求的国际指南

2022-05-1713
OAAI
Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
2021-01-0132
OAAI
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer

CDKN1B突变和拷贝数变异与管腔型乳腺癌的肿瘤侵袭性相关

2020-12-0413
OAAI
Sixty-Day Mortality Among 520 Italian Hospitalized COVID-19 Patients According to the Adopted Ventilatory Strategy in the Context of an Integrated Multidisciplinary Clinical Organization: A Population-Based Cohort Study
2020-12-0114
OAAI
Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer
2020-03-0257
OAAI